Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RedPoint Oncology
Brookline, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
RedPoint Oncology is developing a targeted, image-guided intratumoral delivery platform for biologic and small molecule therapies, aiming for superior tumor retention, decreased systemic toxicity, and improved efficacy, particularly in therapy-resistant solid tumors; preclinical studies are ongoing with no published clinical results yet[1][3].
- Therapeutic areas
- Oncology
- Modalities
- BiologicSmall moleculeBiomaterial-based drug delivery
- Industry
- Biotech
02
Partnerships
Center for the Advancement of Science in Space (CASIS)BoeingInternational Space Station National LaboratoryMassChallenge (startup accelerator)
Beyond the preview
Go deeper on RedPoint Oncology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RedPoint Oncology.